glp 1 drugs GLP-1 Agonists: A Comprehensive Overview GLP-1 Drugs: Fighting Diabetes and

Consequently, apparent reductions in colorectal or liver cancer risk should not be interpreted as evidence of cancer prevention but rather as signals warranting further investigation

To clarify, my understanding is that 'Meridia' (Abbott) was voluntarily withdrawn from the market rather than being banned

: Credits SUN PHARMA #pharmivonmedia #IndustryNews #SunPharma #DCGI #WeightLossTherapy #PharmaInnovation #IndianPharma #HealthcareNews #pharmacy #healthcare #pharmd #medical #industry To view or add a comment, sign in Indias pharma market continues to expand, reaching 2.4 lakh crore in 2025 and projecting ~8% growth in 2026

Goodman et al

head-up position for induction of anaesthesia